FAA Advisory ays System Failure Is Impacting Flights Nationwide, Flights Reportedly Grounded Across US

https://twitter.com/ALorenzoTV/status/1613130786949009409

January 11, 2023

1 minute read

FAA OUTAGE ✈️ 🚨

An @FAANews advisory says a system failure is impacting flights nationwide. Reports coming in that flights are grounded everywhere.

Techs are working to restore the system but there’s no timeframe for when that could happen. @WFTV pic.twitter.com/F6rqIm163s

— Alexa Lorenzo (@ALorenzoTV) January 11, 2023

GameStop Partners With Crypto Exchange FTX: What You Need To Know

By Samyuktha Sriram

Today, 5:26 AM

Major video game retailer GameStop Corp. (NYSE: GME) has partnered with cryptocurrency exchange FTX to bring more customers to the digital asset space.

$DOGE

Viking Therapeutics Announces Results From Phase 1 Clinical Trial Of Novel Oral Thyroid Receptor Beta Agonist VK0214; Says VK0214 ‘demonstrated encouraging safety and tolerability, as well as a predictable pharmacokinetic (PK) profile’

By Bill Haddad

Today, 5:26 AM

Viking Therapeutics, Inc. (Viking) (NASDAQ:VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced results from the

VKTX

Why Enzo Biochem Stock Is Skyrocketing After Hours

By Adam Eckert

Today, 5:26 AM

Enzo Biochem Inc (NYSE: ENZ) shares are soaring in extended trading Thursday after the company agreed to sell its clinical lab to Laboratory Corporation Of America</

ENZ

Is Starbucks Stock Overvalued Or Undervalued?

By Wayne Duggan

Today, 5:26 AM

Starbucks Corporation (NASDAQ: SBUX) shares have lagged the S&P 500 in 2021, generating a year-to-date total return of 8.9%. At this point, investors may be wondering whether Starbucks shares are undervalued after their recent performance.

SBUX

FAA Advisory ays System Failure Is Impacting Flights Nationwide, Flights Reportedly Grounded Across US

Related Posts

GameStop Partners With Crypto Exchange FTX: What You Need To Know

Viking Therapeutics Announces Results From Phase 1 Clinical Trial Of Novel Oral Thyroid Receptor Beta Agonist VK0214; Says VK0214 ‘demonstrated encouraging safety and tolerability, as well as a predictable pharmacokinetic (PK) profile’

Why Enzo Biochem Stock Is Skyrocketing After Hours

Is Starbucks Stock Overvalued Or Undervalued?